Jiangsu Gensciences lnc.

Quick facts

Phase 3 pipeline

• FRSW107 · Diabetes
  FRSW107 is a small molecule that targets the SGLT2 receptor.
• FRSW117 · Diabetes
  FRSW117 is a small molecule that targets the SGLT2 receptor.

Phase 1 pipeline

• SS109

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Jiangsu Gensciences lnc. portfolio CI brief
• Jiangsu Gensciences lnc. pipeline updates RSS